With federal public health agencies under the helm of Robert F. Kennedy Jr., a longtime vaccine critic, the usual schedule ...

Between 60,000 to 160,000 older adults in the U.S. are hospitalized due to RSV every year and 6,000 to 10,000 of them die, the CDC said.

The first vaccines to guard against the respiratory illness RSV will soon be available for some older adults, ages 60 and over, after the CDC formally backed recommendations for the shots.

The Pfizer vaccine Abrysvo is the only RSV vaccine approved by the FDA for those who are pregnant, according to the CDC. The shot should be given during weeks 32 through 36 of pregnancy.

More RSV vaccines may be on the way, too. Moderna is finishing its Phase 3 trial of an mRNA vaccine for RSV in older adults and expects to submit results to the FDA within the next few months.

The world’s first approved vaccines to combat respiratory syncytial virus should be recommended for all Americans 65 and over, a federal advisory panel decided Wednesday. The Advisory Committee ...

The CDC also plans to use V-Safe, a program developed specifically to monitor Covid-19 vaccine safety that has been redesigned to track other people’s post-vaccine experience with other vaccines.

The CDC has recommended that expectant mothers get an RSV vaccine if they are between 32 and 36 weeks pregnant and will give birth during the fall and winter. (LM Otero/AP) ...

The CDC's Advisory Committee on Immunization Practices on Thursday weighed recommendations for two RSV vaccines for older adults and pregnant people, and a monoclonal antibody for babies and toddlers.

In a nearly unanimous vote, advisors to the Centers for Disease Control and Prevention have recommended a new vaccine to protect infants from respiratory syncytial virus, or RSV, by vaccinating ...